Hospital
Scott County Community Hospital, INC.
Scott County Community Hospital, INC. was paid $3.49M by Medicaid between Jan 2018 and Dec 2024, across 94 billing codes. Its largest line is 99285, emergency room visit (most serious) — 31% of everything it billed.
33Billing provider infoSCOTT COUNTY COMMUNITY HOSPITAL, INC.
ONEIDA, TN 37841
ONEIDA, TN 37841
33aNPI1932646049assigned 01/26/2017
33bProvider typeCritical Access Hospital
28Total paid$3.49M
24GClaims166,028
24DCodes billed94
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Tennessee
Rank by total paid#4 of 15
Median peer was paid$1.48M
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,199 | $390K | |
| 2019 | 21,551 | $418K | |
| 2020 | 22,895 | $350K | |
| 2021 | 26,077 | $518K | |
| 2022 | 32,416 | $675K | |
| 2023 | 25,291 | $702K | |
| 2024incomplete | 12,599 | $434K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 31% | 9,591 | 6,039 | $1.09M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 9,833 | 7,822 | $743K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 7,828 | 5,797 | $709K |
| G0378 | Hospital observation service, per hour | 3.8% | 1,364 | 782 | $133K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.1% | 3,520 | 2,467 | $109K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.0% | 1,459 | 1,204 | $70K |
| 71250 | 2.0% | 2,745 | 1,791 | $68K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.8% | 4,413 | 3,040 | $64K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 13,701 | 8,757 | $48K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.2% | 1,042 | 766 | $43K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 1,752 | 1,267 | $41K |
| 84484 | 1.1% | 5,792 | 3,632 | $40K |
82 more codes
| 80053 | Comprehensive metabolic panel | <1% | 14,619 | $34K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,173 | $32K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 109 | $25K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,372 | $19K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,920 | $19K |
| 83735 | <1% | 7,820 | $18K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,364 | $17K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,798 | $16K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,168 | $12K |
| 83880 | <1% | 2,486 | $12K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,856 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,357 | $10K |
| 83690 | <1% | 2,874 | $9K | |
| 82150 | <1% | 2,844 | $8K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,705 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,389 | $8K |
| 83605 | <1% | 2,007 | $7K | |
| 80306 | <1% | 1,540 | $6K | |
| 85004 | <1% | 3,334 | $5K | |
| 87040 | <1% | 1,212 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 271 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 413 | $4K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 102 | $4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 210 | $4K |
| 82550 | <1% | 1,486 | $3K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 47 | $3K |
| 80047 | <1% | 625 | $2K | |
| 81001 | <1% | 3,190 | $2K | |
| 82553 | <1% | 1,450 | $2K | |
| 81025 | <1% | 910 | $2K | |
| 82805 | <1% | 434 | $2K | |
| 96376 | <1% | 503 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,221 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 573 | $2K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 33 | $1K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 325 | $1K |
| 85730 | <1% | 630 | $1K | |
| 36600 | <1% | 487 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 208 | $1K |
| 85610 | <1% | 743 | $1K | |
| 74018 | <1% | 288 | $990.39 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 558 | $843.09 |
| 87807 | <1% | 139 | $747.70 | |
| 0031A | <1% | 52 | $696.78 | |
| 85379 | <1% | 150 | $694.80 | |
| 81003 | <1% | 1,462 | $608.08 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 896 | $460.97 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 424 | $457.70 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 366 | $355.44 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 15 | $334.12 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 41 | $269.60 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 57 | $216.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 66 | $167.05 |
| 72100 | <1% | 14 | $130.68 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,350 | $124.30 |
| 80299 | <1% | 14 | $120.95 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 26 | $113.42 |
| 80143 | <1% | 17 | $105.98 | |
| 74021 | <1% | 16 | $92.95 | |
| 80076 | <1% | 69 | $87.60 | |
| 86308 | <1% | 55 | $84.72 | |
| 73562 | <1% | 16 | $81.50 | |
| 73610 | <1% | 22 | $76.65 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 144 | $73.44 |
| 96367 | <1% | 26 | $54.26 | |
| 73130 | <1% | 19 | $37.66 | |
| 94664 | <1% | 18 | $32.56 | |
| 85014 | <1% | 52 | $23.15 | |
| 85018 | <1% | 52 | $23.15 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 162 | $22.68 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 53 | $16.72 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 22 | $12.48 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 25 | $11.52 |
| 91303 | <1% | 40 | $0.04 | |
| J1956 | Injection, levofloxacin, 250 mg | 0% | 80 | $0.00 |
| 80320 | 0% | 52 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 29 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 89 | $0.00 |
| J0456 | Injection, azithromycin, 500 mg | 0% | 50 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 103 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 36 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEFTWICH, HAL (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Jellico Medical Center, INC. | Jellico, TN | $750K |
| Careplus Medical INC. | Williamsburg, KY | $110K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.